|
Thrombosis risk factors
Citations 71-80 of 165 total displayed.
|
Past content
(since Dec 2000):
|
- Articles
Randomized, Placebo-Controlled Trial of Dalteparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
- Alain Leizorovicz, Alexander T. Cohen, Alexander G.G. Turpie, Carl-Gustav Olsson, Paul T. Vaitkus, Samuel Z. Goldhaber for the PREVENT Medical Thromboprophylaxis Study Group
Circulation published August 2, 2004, doi:10.1161/01.CIR.0000138928.83266.24
[Abstract]
- Articles
Comparing Warfarin With Aspirin After Biological Aortic Valve Replacement. A Prospective Study
- Tiziano Gherli, Andrea Colli, Claudio Fragnito, Francesco Nicolini, Bruno Borrello, Stefano Saccani, Roberto D’Amico, and Cesare Beghi
Circulation published July 26, 2004, doi:10.1161/01.CIR.0000137122.95108.52
[Abstract]
- Cardiology Patient Pages
Prothrombin 20210 Mutation (Factor II Mutation)
- Elizabeth A. Varga and Stephan Moll
Circulation 2004;110:e15-18e, doi:10.1161/01.CIR.0000135582.53444.87
[Full text]
- Articles
Risk Factors and Recurrence Rate of Primary Deep Vein Thrombosis of the Upper Extremities
- Ida Martinelli, Tullia Battaglioli, Paolo Bucciarelli, Serena Maria Passamonti, and Pier Mannuccio Mannucci
Circulation published July 19, 2004, doi:10.1161/01.CIR.0000137123.55051.9B
[Abstract]
- Clinician Update
Pulmonary Embolism After Coronary Artery Bypass Grafting
- Samuel Z. Goldhaber and U. Joseph Schoepf
Circulation 2004;109:2712-2715, doi:10.1161/01.CIR.0000132616.89315.34
[Full text]
- Clinical Investigations and Reports
Soluble CD40 Ligand, Soluble P-Selectin, Interleukin-6, and Tissue Factor in Diabetes Mellitus: Relationships to Cardiovascular Disease and Risk Factor Intervention
- Hoong Sern Lim, Andrew D. Blann, and Gregory Y.H. Lip
Circulation 2004;109:2524-2528; published online before print as doi:10.1161/01.CIR.0000129773.70647.94
[Abstract]
[Full text]
- Articles
Soluble CD40 Ligand, Soluble P-Selectin, Interleukin-6, and Tissue Factor in Diabetes Mellitus. Relationships to Cardiovascular Disease and Risk Factor Intervention
- Hoong Sern Lim, Andrew D. Blann, and Gregory Y.H. Lip
Circulation published May 10, 2004, doi:10.1161/01.CIR.0000129773.70647.94
[Abstract]
- Correspondence
Serum Myoglobin in Pulmonary Embolism
- Anna Bochowicz, Maciej Kostrubiec, and Piotr Pruszczyk
Circulation 2004;109:e194, doi:10.1161/01.CIR.0000127106.85030.4A
[Full text]
- Brief Rapid Communications
Stent Thrombosis After Successful Sirolimus-Eluting Stent Implantation
- Allen Jeremias, Brett Sylvia, Jonathan Bridges, Ajay J. Kirtane, Brian Bigelow, Duane S. Pinto, Kalon K.L. Ho, David J. Cohen, Lawrence A. Garcia, Donald E. Cutlip, and Joseph P. Carrozza, Jr
Circulation 2004;109:1930-1932; published online before print as doi:10.1161/01.CIR.0000127105.99982.21
[Abstract]
[Full text]
- Clinical Investigations and Reports
Clinical Usefulness of Very High and Very Low Levels of C-Reactive Protein Across the Full Range of Framingham Risk Scores
- Paul M Ridker and Nancy Cook
Circulation 2004;109:1955-1959; published online before print as doi:10.1161/01.CIR.0000125690.80303.A8
[Abstract]
[Full text]
|
|
